Skip to main content

Advertisement

SpringerLink
Log in

Localized Castleman’s disease associated with systemic AA amyloidosis. Regression of amyloid deposits after tumor removal

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Castleman B, Iverson L, Menendez VP (1956) Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer 9:822–830

    Article  PubMed  CAS  Google Scholar 

  2. Frizzera G, Peterson BA, Bayrd ED, Goldman A (1985) A systemic lymphoproliferative disorder with morphologic features of Castleman’s disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol 3:1202–1216

    PubMed  CAS  Google Scholar 

  3. Lachmann HJ, Gilbertson JA, Gillmore JD, Hawkins PN, Pepys MB (2002) Unicentric Castleman’s disease complicated by systemic AA amyloidosis: a curable disease. QJM 95: 211–218

    Article  PubMed  CAS  Google Scholar 

  4. Altiparmak MR, Pamuk GE, Pamuk ON, Dogusoy G (2002) Secondary amyloidosis in Castleman’s disease: review of the literature and report of a case. Ann Hematol 81:336–339

    Article  PubMed  CAS  Google Scholar 

  5. Derici U, Arinsoy T, Ataoglu O, Bali M, Eroglu A, Goker B, Sindel S (2002) Localized Castleman’s disease and nephrotic syndrome not responsive to resection plus colchicine therapy. Ann Hematol 81:399–401

    Article  PubMed  CAS  Google Scholar 

  6. Mandreoli M, Casanova S, Vianelli N, Pasquali S, Zucchelli P (2002) Remission of nephrotic syndrome due to AA amyloidosis and initiation of glomerular repair after surgical resection of localized Castleman’s disease. Nephron 90:336–340

    Article  PubMed  Google Scholar 

  7. Gholam D, Vantelon JM, Al-Jijakli A, Bourhis JH (2003) A case of multicentric Castleman’s disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibody. Ann Hematol 82:766–768

    Article  PubMed  Google Scholar 

  8. Leung KT, Wong KM, Choi KS, Chau KF, Li CS (2004) Multicentric Castleman’s disease complicated by secondary renal amyloidosis. Nephrology (Carlton) 9:392–393

    Article  Google Scholar 

  9. Verbrugghe W, Maes BD, Knockaert DC (2005) Localised plasma-cell type Castleman’s disease and AA-amyloidosis cured by resection. A case report and review of the literature. Acta Clin Belg 60:22–27

    PubMed  CAS  Google Scholar 

  10. Yoshizaki K, Matsuda T, Nishimoto N, Kuritani T, Taeho L, Aozasa K, Nakahata T, Kawai H, Tagoh H, Komori T et al (1989) Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman’s disease. Blood 74:1360–1367

    PubMed  CAS  Google Scholar 

  11. Nishimoto N, Sasai M, Shima Y, Nakagawa M, Matsumoto T, Shirai T, Kishimoto T, Yoshizaki K (2000) Improvement in Castleman’s disease by humanized anti-interleukin-6 receptor antibody therapy. Blood 95:56–61

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, “Laikon” University Hospital, 75 Mikras Asias Str., 115 27, Athens, Greece

    A. Androulaki & K. Giaslakiotis

  2. First Department of Internal Medicine, “Laikon” University Hospital, Athens, Greece

    X. Giakoumi & A. Aessopos

  3. First Department of Pathology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

    A. C. Lazaris

Authors
  1. A. Androulaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Giaslakiotis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. X. Giakoumi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Aessopos
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. C. Lazaris
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K. Giaslakiotis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Androulaki, A., Giaslakiotis, K., Giakoumi, X. et al. Localized Castleman’s disease associated with systemic AA amyloidosis. Regression of amyloid deposits after tumor removal. Ann Hematol 86, 55–57 (2007). https://doi.org/10.1007/s00277-006-0187-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-006-0187-0

Keywords

Search

Navigation